Bioelectronics – Technology Interfaces with the Human Body | The Royal Society
Why It Matters
Bioelectronics bridges the gap between silicon technology and biology, enabling affordable, continuous health monitoring and minimally invasive therapies that could transform patient care worldwide.
Key Takeaways
- •Bioelectronics creates skin-like, stretchable devices for health monitoring
- •Rogers' team translates lab prototypes into FDA‑approved clinical devices
- •Resorbable implants enable temporary cardiac pacing, reducing post‑surgery risks
- •DARPA‑funded epidermal electronics provide wireless ICU‑grade monitoring for soldiers
- •Interdisciplinary approach merges silicon nanomembranes with polymers for flexibility
Summary
The Royal Society’s Bakerian Medal lecture, delivered by Professor John Rogers, focused on bioelectronics – electronic systems designed to integrate seamlessly with soft living tissues. Rogers traced his journey from DARPA‑funded epidermal electronics for battlefield health monitoring to the development of skin‑like, stretchable platforms that can record physiological signals with medical‑grade accuracy.
Key insights included the use of ultra‑thin silicon nanoribbons and polymer composites to achieve flexibility, the translation of these prototypes into FDA and CE‑approved devices for cardiac mapping and neuromodulation, and the creation of resorbable implants that provide temporary cardiac pacing and then safely dissolve. Rogers highlighted the interdisciplinary nature of the work, blending materials science, physics, chemistry, and biomedical engineering.
A memorable example was Rogers describing the device as “a temporary tattoo that can monitor your heart and brain,” and he showcased a resorbable cardiac pacemaker that eliminates the need for surgical removal. He also recounted the historical anecdote about Henry Baker’s bequest, underscoring the lecture’s blend of tradition and cutting‑edge innovation.
The implications are profound: bioelectronic platforms promise continuous, low‑cost health monitoring, reduce invasive procedures, and can be deployed in both high‑income and resource‑limited settings, potentially reshaping the global medical‑device market.
Comments
Want to join the conversation?
Loading comments...